Is Banner Display?
Off
Page Content
#ffffff
Anonymous user
On
Authenticated user
On
Premium
On
Paid / Sponsored
On
Source

Forrest JK, Yakubov SJ, Deeb GM, et al. 5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis. J Am Coll Cardiol. 2025;85(15):1523-1532. doi:10.1016/j.jacc.2025.03.004

Thumbnail
EVOLUT LOW RISK LONG TERM
Speciality
Currency
Sub Speciality
Sub Sub Speciality
Short Description

EVOLUT LOW RISK TRIAL assessed the 5-year clinical and hemodynamic outcomes of transcatheter aortic valve replacement (TAVR) compared to surgical aortic valve replacement (SAVR) in patients enrolled in the Evolut Low Risk trial.

Release Date
Is Paid
0